Ultrasound-Guided Ablation a Suitable Alternative for Refractory SHPT
Ultrasound-guided radiofrequency ablation may result in a shorter hospital stay compared with parathyroidectomy.
Diagnosis & Disease Information
SHPT Treatment Tied With Lower Dementia Risk
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
Cinacalcet Does Not Up Risk for Severe Gastrointestinal Bleeding in Hemodialysis
Study is the largest to explore this potential safety issue to date.
Pro-Inflammatory Diet Associated With Elevated Parathyroid Hormone Levels
In a cross-sectional study, hyperparathyroidism occurred more frequently in adults with a diet of high vs low inflammatory potential.
Etelcalcetide Shows Efficacy in Clinical Practice
Patients on hemodialysis who have secondary hyperparathyroidism experienced a 40% reduction in PTH levels over 12 months of etelcalcetide treatment, investigators reported.
Anemia, SHPT Are Possible Cardiovascular Risk Factors in Kidney Transplant Recipients
In a small study, approximately a third of kidney transplant recipients had anemia and half had persistent secondary hyperparathyroidism.
High iPTH Linked With Cardiovascular Outcomes in Diabetic Kidney Disease
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
SHPT Linked With Weight Loss, Death
Weight loss partly accounted for the association between high parathyroid hormone levels and mortality among patients on hemodialysis.
Results Mixed for Vitamin D Supplementation in SHPT
Gaps in the evidence-base for the management of vitamin D status in relation to CKD-MBD are hindering the formulation of comprehensive guidelines, according to investigators.
SHPT Management Found to Vary by Specialty
Unlike endocrinologists and surgeons, nephrologists tended to treat patients with calcimimetics rather than subtotal parathyroidectomy.
- Loading...
Loading...
Next post in Secondary Hyperparathyroidism
Loading... 
Loading...